LEADER 01235nam0 22003011i 450 001 UON00210212 005 20231205103331.755 010 $a97-220-1380-7 100 $a20030730d1997 |0itac50 ba 101 $apor 102 $aPT 105 $a||||0 ||||| 200 1 $aContra a corrente$fManuel Alegre$gprefácio de António Reis 210 $aLisboa$cPublicaçoes Dom Quixote$d1997. XI$d283 p.$d16 c. di tav., foto ; 21 cm. 606 $aPORTOGALLO$xPolitica$xSec 20.$xTesti e documenti$3UONC043996$2FI 606 $aPORTOGALLO$xDiscorsi politici$3UONC043997$2FI 606 $aDISCORSI POLITICI$xPortogallo$3UONC043998$2FI 620 $aPT$dLisboa$3UONL003135 676 $a320.9469$cSituazione e condizioni politiche. Portogallo$v21 700 1$aALEGRE$bManuel$3UONV108406$0253882 702 1$aREIS$bAntónio$3UONV126483 712 $aDom Quixote$3UONV264466$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00210212 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI Port STO 421 $eSI LO 62997 7 421 996 $aContra a corrente$91260340 997 $aUNIOR LEADER 03408nam 2200577Ia 450 001 9910437834303321 005 20200520144314.0 010 $a94-007-6467-7 024 7 $a10.1007/978-94-007-6467-5 035 $a(CKB)2670000000372385 035 $a(EBL)1697553 035 $a(OCoLC)843401902 035 $a(SSID)ssj0000894263 035 $a(PQKBManifestationID)11932485 035 $a(PQKBTitleCode)TC0000894263 035 $a(PQKBWorkID)10834885 035 $a(PQKB)11223636 035 $a(DE-He213)978-94-007-6467-5 035 $a(MiAaPQ)EBC1697553 035 $a(PPN)170494764 035 $a(EXLCZ)992670000000372385 100 $a20130522d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAngiogenesis modulations in health and disease $epractical applications of pro-and anti-angiogenesis targets /$fShaker A. Mousa, Paul J. Davis, editors 205 $a1st ed. 2013. 210 $aDordrecht ;$aNew York $cSpringer$dc2013 215 $a1 online resource (209 p.) 300 $aDescription based upon print version of record. 311 $a94-017-8515-5 311 $a94-007-6466-9 320 $aIncludes bibliographical references and index. 327 $aPreface -- Angiogenesis assays: an appraisal of current techniques -- Survey of pro-angiogenesis strategies -- Angiogenesis modulation by arachidonic acid ? derived lipids: positive and negative regulators of angiogenesis -- Pro-angiogenic activity of thyroid hormone analogues: Mechanisms, physiology and clinical prospects -- Actions of steroids and peptide hormones on angiogenesis -- Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis modulation.-  Catecholamine neurotransmitters: an angiogenic switch in the tumor microenvironment -- Impact of nanotechnology on therapeutic angiogenesis -- Survey of anti-angiogenesis strategies -- Tetraiodothyroacetic acid (tetrac), nanotetrac and anti-Angiogenesis -- Integrin antagonists and angiogenesis -- Anti-angiogenesis therapy as an adjunct to chemotherapy in oncology -- Anti-vegf strategies in ocular angiogenesis- mediated disorders, with special emphasis on age-related macular degeneration -- Application of nanotechnology to targeting tumor angiogenesis for therapeutic benefit -- Biomarkers of response and resistance to anti-angiogenic treatment -- Speculations on new directions in which angiogenesis may proceed. Index. 330 $a This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets. 606 $aNeovascularization 606 $aBlood vessels$xGrowth 615 0$aNeovascularization. 615 0$aBlood vessels$xGrowth. 676 $a610 701 $aMousa$b Shaker A$0556586 701 $aDavis$b Paul J$01763139 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910437834303321 996 $aAngiogenesis modulations in health and disease$94203427 997 $aUNINA